Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT05101382
Recruiting Observational

A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)

NCT05101382 · tracked via the Priya Life Science Spain tracker
Sponsor
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase
Observational
Started
2020-10-28
Last updated
2025-08-24

Condition(s) studied

Colorectal Cancer

Investigational drug(s) / intervention(s)

Observation

Observation: Retrospective Observation of standard clinical practice

Study summary

ALFAOMEGA-RETRÒ will be exploited to retrospectively collect clinical and imaging data and archival samples to be used for validation and correlative studies on markers discovered by cutting-edge translational projects within the AIRC5x1000 program "Insights into the evolving heterogeneity of colorectal cancer (CRC): from mechanism to therapies" (an ongoing multi-institutional research program).

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Histologically-confirmed diagnosis of colorectal cancer (any stage). * Age \>18 years at the time of diagnosis. * Availability of clinically-annotated radio-imaging data and/or diagnostic Formalin-Fixed Paraffin Embedded (FFPE) blocks (surgical resections and/or tumor biopsies), or at least 10 slides (preferably 20). FFPE tissue blocks are always preferred to slides. * Verification that the patient could not be reached for informed consent in accordance with applicable national regulations. Exclusion Criteria: * if inclusion criteria are not met

Primary outcome measure(s)

  • Number of retrospectively recruited CRC cases — 6 months
    Number of retrospectively recruited CRC cases with complete matched clinical data, radio-imaging data and FFPE or frozen biological samples.

Trial sites (13)

FacilityCityRegionStatus
Ospedale Policlinico San Martino Genova GE Recruiting
Fondazione IRCCS, Istituto Nazionale dei Tumori Milan MI Recruiting
Niguarda Cancer Center - ASST Grande Ospedale Metropolitano Niguarda Milan MI Recruiting
IRCCS Istituto Clinico Humanitas Milan MI Recruiting
Istituto Oncologico Veneto (IOV) Padua PD Recruiting
Azienda Ospedaliero Universitaria Pisana Pisa Pisa Recruiting
Istituto di Candiolo - IRCCS Candiolo TO Recruiting
Azienda Ospedaliero Universitaria San Luigi Gonzaga Orbassano TO Recruiting
Azienda Ospedaliera Ordine Mauriziano Torino TO Active Not Recruiting
Institut Català D'Oncologia (ICO) L'Hospitalet de Llobregat Barcelona Recruiting
Hospital del Mar - Parc de Salut Mar Barcelona Spain Recruiting
Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain Recruiting
INCLIVA - Instituto de Investigatión Sanitaria Valencia Spain Recruiting

More IFOM ETS - The AIRC Institute of Molecular Oncology trials in Spain

ALFAOMEGA Master Observational Trial Recruiting
The Sagittarius Trial Recruiting

Other trials for the same condition

Comparing Polypropylene Mesh and "Small Bites" Technique in Emergency Colorectal Surgery's Midline Laparotomy Closure. Study for Incisional Hernia Prevention. Recruiting
Stage II/III Colorectal Cancer Recurrence Recruiting
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours Recruiting
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Active, not recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05101382 on ClinicalTrials.gov ↗ ← All trials in Spain